People who received the corona vaccine from AstraZeneca before its use was stopped in Norway will be offered Pfizer or Moderna vaccines for their second two.
The Norwegian government decided to follow the recommendation from the National Institute of Public Health (FHI).
“There is a need for a clarification on dose two before the Vorland Committee submits its report. Therefore, those who have received one dose of the AstraZeneca vaccine will be offered a second dose of Pfizer-BioNTech or Moderna,” Minister of Health and Care Services Bent Høie (H) noted in a press release.
Norway stopped using the AstraZeneca vaccine on March 11 after reports of cases of blood clots in people who received the vaccine.
By May 10, the Vorland Committee will assess the risk of using the AstraZeneca and Janssen vaccines. The use of the vaccines has been suspended until then.
Around 135,000 people have been vaccinated with AstraZeneca in Norway. 90% of those vaccinated are health professionals. The first vaccinations took place in week six, while most received it between week eight and ten.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at firstname.lastname@example.org